Lexeo takes mantle 8m acquisition friedreich ataxia assets

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 24 Sept, 12:07 UTC

Lexeo Therapeutics has agreed to acquire Mantle Therapeutics via an upfront payment of $8.3 million, aiming to expand its Friedreich ataxia (FA) portfolio while locking in three strategic collaborations to support its lead asset.

businessfintechscience

Sources

• T2Lexeo takes mantle 8m acquisition friedreich ataxia assetsFierce Biotech / Fierce Healthcare / MedCity / GEN24 Sept, 12:07